• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Orexigen Therapeutics Inc

+ Add to Watchlist

OREX:US

5.6800 USD 0.0900 1.56%

As of 20:10:00 ET on 08/21/2014.

Snapshot for Orexigen Therapeutics Inc (OREX)

Open: 5.7900 Day's Range: 5.6100 - 5.7900 Volume: 2,553,988
Previous Close: 5.7700 52wk Range: 4.5950 - 7.8200 1-Yr Rtn: -18.39%

Stock Chart for OREX

No chart data available.
  • OREX:US 5.6700
  • 1D
  • 1M
  • 1Y
5.7700
Interactive OREX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OREX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8400
Est. EPS (USD) (12/2014) -0.1700
Est. PEG Ratio -
Market Cap (M USD) 696.00
Shares Outstanding (M) 122.53
30 Day Average Volume 2,577,728
Price/Book (mrq) 1,272.3599
Price/Sale (ttm) 176.3430
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OREX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OREX

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for OREX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil